Cardiotoxicity as undesired side effect in the treatment of breast cancer
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
Improvement of methods used in breast cancer therapy resulted in increased treatment effectiveness and prolonged survival of patients. However, this is accompanied by increased frequency of adverse side effects, including cardiac toxicity, which is becoming a serious problem affecting the quality of life and overall survival of cancer patients. The risk of developing cardiovascular complications depends on the type and dose of therapeutic agent used. The highest risk of cardiotoxicity is associated with anthracyclines. They are used frequently in cancer therapy due to their high efficiency but show a dose-dependent toxicity to the cardiovascular system. Cardiotoxicity can also occur with other substances used in breast cancer chemotherapy, as well as with radiotherapy. Combining potentially cardiotoxic therapeutic agents, commonly used in combination therapy, may result in escalation of toxic side effects. Mechanisms of heart damage are different for various cardiotoxic agents, but symptoms usually involve heart failure, ischemic heart disease, arrhythmias, hypertension, valvular diseases or pericarditis and myocarditis. The practices used to reduce the risk of cardiotoxic effects of cancer therapy include evaluation of cardiac functions before treatment and constant monitoring during and after treatment. Furthermore, limited doses and modifications of anticancer agent administration patterns are employed, as well as simultaneous application of cardioprotective agents. Understanding of cardiotoxic mechanisms of agents used in breast cancer treatment can help to develop efficient cardioprotective substances. Because oxidative stress plays an important role in the toxicity of cancer therapy, compounds with antioxidant properties are a very promising target of research.
Authors and Affiliations
Michalina Gramatyka
Keywords
Related Articles
- EP ID EP67357
- DOI -
- Views 128
- Downloads 0
Protrusive and retractive structures formed during cell migration
Cell migration is essential to many physiological processes; however, it is also a cause of cancer metastasis formation and other pathological phenomena. Due to structural and functional variety of cells, a variety of st...
Zmiany mięśni szkieletowych w trakcie starzenia: fizjologia, patologia i regeneracja
W pracy przedstawiono zmiany zachodzące w mięśniach szkieletowych podczas starzenia się organizmu ludzkiego. Wraz z postępującym wiekiem dochodzi do fizjologicznego spadku masy mięśni szkieletowych, określanego mianem s...
Ibudilast: a non-selective phosphodiesterase inhibitor in brain disorders
Ibudilast (IBD) is a non-selective (3, 4, 10, 11) phosphodiesterase (PDE) inhibitor, used mainly as a bronchodilator for the treatment of bronchial asthma. PDE play a central role in cellular function (e.g. differentiati...
Mikroewolucja podszczepów BCG
Gruźlica stanowiła i nadal stanowi jedną z głównych przyczyn zachorowalności i umieralności na świecie. Jej zwalczanie pozostaje priorytetem zdrowia publicznego, trudnym do zrealizowania bez zastosowania nowo opracowanej...
Intracellular glutathione level and efflux in human melanoma and cervical cancer cells differing in doxorubicin resistance
Introduction: Drug resistance continues to be a major problem in cancer treatment. Occurrence of this phenomenon is often associated with altered levels of glutathione (GSH) and GSH-related enzymes. The aim of the study...